BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4625606)

  • 21. Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments.
    Forrest WA
    Curr Med Res Opin; 1978; 5(9):669-74. PubMed ID: 104825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 24. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
    Olowoyeye JO; Thadani U; Parker JO
    Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
    Aellig WH; Prichard BN; Richardson GA
    Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
    [No Abstract]   [Full Text] [Related]  

  • 26. Slow release oxprenolol in angina pectoris [proceedings].
    Goldstraw PW; Taylor SH; Thadani U; Watt SJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P. PubMed ID: 332219
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical evaluation of oxprenolol in angina pectoris.
    Sandler G; Pistevos A
    Br Heart J; 1972 Aug; 34(8):847-50. PubMed ID: 4560824
    [No Abstract]   [Full Text] [Related]  

  • 28. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
    Hickie JB
    Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977
    [No Abstract]   [Full Text] [Related]  

  • 29. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
    Dagenais GR; Pitt B; Ross RS
    Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
    Reynolds JL; Whitlock RM
    Br Heart J; 1972 Mar; 34(3):252-9. PubMed ID: 4111391
    [No Abstract]   [Full Text] [Related]  

  • 31. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemodynamic changes during practolol administration under various stress conditions in angina pectoris].
    Stauch M; Härich BK; Schäfer N
    Verh Dtsch Ges Kreislaufforsch; 1971; 37():176-9. PubMed ID: 5140980
    [No Abstract]   [Full Text] [Related]  

  • 33. A double blind trial of LB-46 in the treatment of angina pectoris.
    Raychaudhuri B; Das MR; Neelakatan C; Chaudhuri ND; Bose J; Chetri MK
    Indian Heart J; 1973 Jan; 25(1):58-61. PubMed ID: 4576304
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coronary and left ventricular dynamics of three substances with different beta-blocking effects: Propranolol, Pindolol, and Practolol].
    Moccetti T; Halter J; Lichtlen P
    Schweiz Med Wochenschr; 1972 Mar; 102(12):422-5. PubMed ID: 4401753
    [No Abstract]   [Full Text] [Related]  

  • 35. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multi-centric study of angina pectoris under oxprenolol treatment combined with nitrates in the Trivento region].
    Dalla Volta S; D'Amelio G
    Minerva Cardioangiol; 1980; 28(7-8):475-80. PubMed ID: 7005710
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
    Gasparotto G; Pagnan A
    Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
    [No Abstract]   [Full Text] [Related]  

  • 38. Angina pectoris.
    Taylor SH
    Br Med J; 1971 Jun; 2(5763):713. PubMed ID: 4253966
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of dextro-alprenolol, dextro-propranolol and practolol in the treatment of ventricular ectopic beats.
    Smith E; Bennet D; Sowton E
    Guys Hosp Rep; 1971; 120(1):9-15. PubMed ID: 4397736
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double-blind test of C.39'089-Ba in angina pectoris].
    Mantykow JE; Lepera L; Slafer H; Conti L; Lo Russo J
    Prensa Med Argent; 1970 Aug; 57(24):1209-12. PubMed ID: 4918476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.